- Home
- FBIO vs FCO Comparison
FBIO vs FCO Comparison
Compare FBIO & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- FCO
- Stock Information
- Founded
- FBIO 2006
- FCO 1991
- Country
- FBIO United States
- FCO United Kingdom
- Employees
- FBIO N/A
- FCO N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- FCO Investment Managers
- Sector
- FBIO Health Care
- FCO Finance
- Exchange
- FBIO Nasdaq
- FCO Nasdaq
- Market Cap
- FBIO 88.7M
- FCO 85.6M
- IPO Year
- FBIO N/A
- FCO N/A
- Fundamental
- Price
- FBIO $3.59
- FCO $6.68
- Analyst Decision
- FBIO Strong Buy
- FCO
- Analyst Count
- FBIO 2
- FCO 0
- Target Price
- FBIO $16.50
- FCO N/A
- AVG Volume (30 Days)
- FBIO 1.2M
- FCO 100.1K
- Earning Date
- FBIO 08-14-2025
- FCO 01-01-0001
- Dividend Yield
- FBIO N/A
- FCO 14.96%
- EPS Growth
- FBIO N/A
- FCO N/A
- EPS
- FBIO N/A
- FCO 0.43
- Revenue
- FBIO $59,301,000.00
- FCO N/A
- Revenue This Year
- FBIO $51.59
- FCO N/A
- Revenue Next Year
- FBIO $44.74
- FCO N/A
- P/E Ratio
- FBIO N/A
- FCO $12.30
- Revenue Growth
- FBIO N/A
- FCO N/A
- 52 Week Low
- FBIO $1.33
- FCO $4.73
- 52 Week High
- FBIO $3.90
- FCO $6.63
- Technical
- Relative Strength Index (RSI)
- FBIO 79.40
- FCO 56.58
- Support Level
- FBIO $2.79
- FCO $6.61
- Resistance Level
- FBIO $3.90
- FCO $6.71
- Average True Range (ATR)
- FBIO 0.25
- FCO 0.06
- MACD
- FBIO 0.14
- FCO -0.01
- Stochastic Oscillator
- FBIO 83.77
- FCO 63.23
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.